Due to its social mission to improve the equity of access to basic medical supplies, Barakat Pharmaceuticals Company has launched projects to manufacture generic drugs in order to substitute the import of drugs, which have led to the following:
Manufacturing High-Tech Anti-Cancer Drugs
Cancer is the third most common cause of death in Iran (35.000 cases) ranking the country the 17th in the world. The amount of money paid for anti-cancer drugs in the country in 2012 was 142.857 dollars. Sobhan Oncology Company is a pioneer producer of anti-cancer drugs in the region.
Annually, cancer patients, who already bear the anguish of their illness, have to pay thousands of dollars for the excessive prices of anti-cancer drugs made by special technology. On the one hand, this company by manufacturing such medicinal products, and establishing good relations with reputable companies worldwide including Sanofi, Rash Switzerland and etc., and licensing agreement, has been able to offer this group of products at lower prices, even up to one fifth of the prices of similar products made by foreign companies. On the other hand, because it is forecasted that by 2016 the annual use of anti-cancer drugs in the world will increase over 83 billion dollars, which will have the highest use portion among other drug groups, and that neighboring countries of Iran especially countries to its north will have the highest overall cancer rate in the region, Sobhan Oncology Company as one of the most modern companies in the region can export its anti-cancer drugs to these countries. The company hopes to make a valuable contribution in the treatment of patients. Sobhan Oncology Company, by manufacturing the first Nano-drug (Doxorubicin Liposomal Nano-drug) in partnership with an Iranian knowledge-based company, has made Iran the second country after the U.S. in manufacturing such drugs.
E-Health Social Plan (Barakatel Company)
This great national project is being implemented at BarakaTel Company. Usually, one of the problems pertaining to health equity and the issue of social justice in healthcare is taking appropriate and on-time measures providing communities living in remote and deprived areas with medical services. Following the efforts pertaining to delivering such relief to the people living in impoverished areas, Barakat Pharmaceuticals, in constructive cooperation with the Ministry of Health and Medical Education, has attempted to institutionalize an e-health plan to eradicate deprivation in the community. In addition, the company has focused on doing e-health related projects in this plan including call centers, smart hospital beds, the quintet package, desktop mobile health, mobile health, electronic systems and so on to improve community health in impoverished areas. By creating a call center, this company has established an e-counseling center between patients and the medical community, in which consultants and specialists answer people’s questions at any time during the day, night or even during holidays. Installing smart hospital beds which can transmit the full medical examination of children and adults to an advanced processing center located in medical centers in a short time, and establishing desktop mobile health system in order to utilize minimum laboratory services at doctors’ offices and medical clinics and transmitting the data to a data center and cell phones especially on a pilot basis in deprived areas such as the cities of Paveh, Andika, Lali and so on, has created health and improved the life expectancy in those areas and prevented many problems and consequences related to the lack of medical facilities. By utilizing the provided capacities, facilities and infrastructure, all the residents of those areas are under e-care.
Meanwhile, more than 32 million people of the country population have medical records in the electronic health systems- the largest health information and continuing care center- and their information is recorded and maintained in the system.